AIMC Topic: Drug Combinations

Clear Filters Showing 61 to 70 of 89 articles

A review of machine learning approaches for drug synergy prediction in cancer.

Briefings in bioinformatics
Combinational pharmacotherapy with the synergistic/additive effect is a powerful treatment strategy for complex diseases such as malignancies. Identifying synergistic combinations with various compounds and structures requires testing a large number ...

SynPathy: Predicting Drug Synergy through Drug-Associated Pathways Using Deep Learning.

Molecular cancer research : MCR
UNLABELLED: Drug combination therapy has become a promising therapeutic strategy for cancer treatment. While high-throughput drug combination screening is effective for identifying synergistic drug combinations, measuring all possible combinations is...

An enhanced cascade-based deep forest model for drug combination prediction.

Briefings in bioinformatics
Combination therapy has shown an obvious curative effect on complex diseases, whereas the search space of drug combinations is too large to be validated experimentally even with high-throughput screens. With the increase of the number of drugs, artif...

PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein-protein interaction network.

Briefings in bioinformatics
Although drug combinations in cancer treatment appear to be a promising therapeutic strategy with respect to monotherapy, it is arduous to discover new synergistic drug combinations due to the combinatorial explosion. Deep learning technology holds i...

DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations.

Briefings in bioinformatics
MOTIVATION: Drug combination therapy has become an increasingly promising method in the treatment of cancer. However, the number of possible drug combinations is so huge that it is hard to screen synergistic drug combinations through wet-lab experime...

Machine learning methods, databases and tools for drug combination prediction.

Briefings in bioinformatics
Combination therapy has shown an obvious efficacy on complex diseases and can greatly reduce the development of drug resistance. However, even with high-throughput screens, experimental methods are insufficient to explore novel drug combinations. In ...

Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting.

African health sciences
BACKGROUND: Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil (E/C/F/TDF) in treatment-naïve and experienced patients with HIV infection was demonstrated in phase 3 trials. The primary objective of this study was to evaluate effe...

Comparative analysis of molecular fingerprints in prediction of drug combination effects.

Briefings in bioinformatics
Application of machine and deep learning methods in drug discovery and cancer research has gained a considerable amount of attention in the past years. As the field grows, it becomes crucial to systematically evaluate the performance of novel computa...

GraphSynergy: a network-inspired deep learning model for anticancer drug combination prediction.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVE: To develop an end-to-end deep learning framework based on a protein-protein interaction (PPI) network to make synergistic anticancer drug combination predictions.

Deep learning identifies synergistic drug combinations for treating COVID-19.

Proceedings of the National Academy of Sciences of the United States of America
Effective treatments for COVID-19 are urgently needed. However, discovering single-agent therapies with activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been challenging. Combination therapies play an important role i...